OLAW Not Accepting Requests for Semiannual Facility Inspection Waivers Due to COVID-19 as of October 1, 2022

Effective October 1, 2022, the NIH Office of Laboratory Animal Welfare (OLAW) will no longer accept requests for waivers to conduct the semiannual facility inspections due to COVID-19.

Guidance for Applicants Preparing Applications for Summer 2022 Due Dates During the COVID-19 Pandemic

For applicants preparing applications for the summer 2022 due dates, NIH recently extended the guidance that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch.

Are COVID-19 Flexibilities Related to Animal Care and Use Still in Effect?

Yes. The flexibilities allowed by the NIH Office of Laboratory Animal Welfare are continuing due to the recent surges in the COVID-19 pandemic throughout the country and the impact on institutions’ operations. Read on for more details.

Extending Existing Guidance for Preparing Applications During COVID-19 

For Spring 2022 due dates, NIH recently extended the guidance that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch. NIH also extended the special exception for post-submission material to applications submitted for the August/October 2022 Council rounds.

Reminder of COVID-19-Related Flexibilities for NIH Grants

When the public health emergency was first declared, NIH, working with OMB and HHS, quickly identified a long list of flexibilities to support the research community. The list has evolved since the pandemic began, so we would like to take this opportunity to remind the community of many of the current flexibilities we have in place.

Clarified Guidance for Applicants Preparing Applications During the COVID-19 Pandemic

NIH recently issued a clarification indicating that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch.

Updated NIH-wide Strategic Plan for COVID-19 Research Now Available

NIH recently released its updated Strategic Plan for COVID-19 Research, available on the NIH COVID-19 website. Responses to a Request for Information helped inform this iteration, building on progress since the 2020 plan. The updated strategic plan highlights progress made in the development of diagnostics, therapeutics, and vaccines, along with developing strategies on how to effectively provide these resources.

Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic

Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 Pathway to Independence award. Due to disruptions caused by the COVID-19 pandemic, NIH will be extending the two-receipt cycle extension (roughly eight additional months) of eligibility for prospective, eligible candidates for a K99/R00 application.

The Impact of the COVID-19 Pandemic on the Extramural Scientific Workforce – Outcomes from an NIH-Led Survey

At NIH, we recognized the many ways the COVID-19 pandemic could adversely affect the biomedical workforce, particularly members of underrepresented groups and vulnerable populations. In October 2020, NIH fielded two online surveys to objectively document COVID-19’s impact on extramural research. One survey assessed the perspective of individual research administration leaders at extramural institutions, and the other survey assessed the perspective of the researchers themselves. In this post, we offer a high-level overview of general trends noted within both surveys.

Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19

The COVID-19 pandemic, along with extensive mitigation measures, has adversely affected progress in many biomedical research settings. Evidence from multiple sources, including a survey NIH issued to its supported extramural research workforce last fall, indicates legitimate concerns about career trajectory for early career scientists, including those with caretaker responsibilities. An article by Dr. Erin Gibson and her colleagues argued for a “reset” with focus on early career investigators. One point I took away from this paper is that a reset does not necessarily mean for us to go “back to normal” after the pandemic is over, because that time may have favored certain investigators and disfavored others (something I reflected on in this video and this blog).

Hearing your concerns, NIH issued a Guide Notice last week detailing our approach to support early career scientists whose career trajectories may have been significantly affected by the pandemic as funding will allow). Specifically, NIH is providing an opportunity for recipients in their last year of NIH Fellowship (“F”) and NIH Career Development (“K”) awards who have been impacted by COVID-19 to request extensions. Such extensions will be considered on a case-by-case basis, within the existing constraints of available funding. We encourage you to read the Guide Notice and if appropriate reach out to NIH staff as directed.